|Bid||51.00 x 3200|
|Ask||51.01 x 1000|
|Day's range||50.90 - 51.10|
|52-week range||44.11 - 55.00|
|Beta (5Y monthly)||0.39|
|PE ratio (TTM)||8.71|
|Forward dividend & yield||1.91 (3.76%)|
|Ex-dividend date||03 May 2021|
|1y target est||N/A|
Pfizer CEO sees need for a third vaccine dose as Moderna updates its timeline on third booster shot. Pause on the Johnson & Johnson vaccine remains. Yahoo Finance’s Anjalee Khemlani breaks down the details.
FDA & CDC temporarily halt J&J's (JNJ) COVID-19 vaccine use. Merck (MRK) ends development of COVID-19 drug.
Dr. Taison Bell, Assistant Professor of Medicine in the divisions of Infectious Diseases and Pulmonary & Critical Care Medicine at the University of Virginia, joins Yahoo Finance’s Kristin Myers and Alexis Christoforous to discuss the latest on the coronavirus.